NCT03827551 (PARKIDENT) is a NA clinical trial of Delivery of oral hygiene advices in Oral Health, sponsored by University Hospital, Bordeaux.

Who is sponsoring NCT03827551?

NCT03827551 is sponsored by University Hospital, Bordeaux.

What drugs are being tested in NCT03827551?

Interventions in NCT03827551: Delivery of oral hygiene advices.

What condition does NCT03827551 study?

NCT03827551 studies Oral Health, Parkinson Disease.

Is NCT03827551 still recruiting?

NCT03827551 is currently completed. Last updated 28 September 2021.

Last reviewed 2021-09-28 · How we verify

NCT03827551: PARKIDENT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Preliminary Study of the Quality of the Oral Flora in Parkinson's Patients

Completed NA Last updated 28 September 2021

What this trial tests

NA trial testing Delivery of oral hygiene advices in Oral Health in 40 participants. Completed in 6 April 2021.

Timeline

29 April 2019

Primary endpoint
6 April 2021

6 April 2021

Quick facts

Lead sponsor	University Hospital, Bordeaux
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	40
Start date	29 April 2019
Primary completion	6 April 2021
Estimated completion	6 April 2021
Sites	1 location across France

Drugs / interventions tested

Delivery of oral hygiene advices

Conditions studied

Oral Health — all drugs for Oral Health →
Parkinson Disease — all drugs for Parkinson Disease →

Sponsor

University Hospital, Bordeaux

Who can join

18 and older, any sex, with Oral Health or Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective interventional clinical study whose main objective is to determine the impact of oral hygiene guidance on the oral health status of patients with Parkinson disease

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Serotype and distribution of adhesion genes in Streptococcus mutans isolated from people with Parkinson's disease.
Donnet L, Claisse O, Samot J. · · 2025 · cited 2× · PMID 40048130 · DOI 10.1007/s10266-025-01078-5
Periodontal health in a longitudinal French cohort of people with Parkinson's disease.
Samot J, Courtin E, Guehl D, Damon-Perriere N, et al · · 2026 · PMID 42249009 · DOI 10.1038/s41598-026-55641-3
Defense Systems and Prophage Detection in Streptococcus mutans Strains.
Claisse O, Mosterd C, Marrec CL, Samot J. · · 2026 · PMID 41215733 · DOI 10.1111/omi.70014
Periodontal health in a French cohort of people with Parkinson’s disease
Samot J, Courtin E, Guehl D, Damon-Perriere N, et al · · 2024 · DOI 10.1101/2024.09.29.24314316

Verify or expand the search:

Other recruiting trials for Oral Health

Currently open trials in the same condition.

NCT07467538 — Ecofriendly Versus Nylon Tooth Brushes on Cariogram Outcomes · NA · active not recruiting
NCT07295197 — Oral Indicators for ED Screening · recruiting
NCT06969092 — A Study on the Correlation Between Oral Health and Delirium in Surgical Inpatients · recruiting
NCT06912451 — Sport Mouthguards: Devices for Preventing Dental Injuries in Sports · NA · recruiting
NCT06855693 — Involving Parents to Improve Tooth Brushing for Autistic Children. · NA · active not recruiting

Other University Hospital, Bordeaux trials

Trials by the same sponsor.

NCT07506928 — NEURO - Prognostication Using Late Somatosensory Evoked - Potentials · NA · not yet recruiting
NCT07524036 — Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan. · NA · not yet recruiting
NCT07527494 — Digital MEDIcal TWIN for the Prediction of Arrhythmic Sudden Cardiac Death After a Myocardial Infarction · NA · not yet recruiting
NCT07527442 — Efficacy and Safety of Circumcision Alone on Risk of Febrile Urinary Tract Infections in Boys With Posterior Urethral Va · Phase 2 · not yet recruiting
NCT07478523 — FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03827551 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Bordeaux
Last refreshed: 28 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03827551.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing